Zhenhua Wu
0000-0003-4552-883X
Publication & Citation Trends
Publications
0 total
Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer OA
Cited by 19
Semantic Scholar
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer OA
Cited by 4
Semantic Scholar
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators OA
Cited by 70
Semantic Scholar
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer. OA
Cited by 73
Semantic Scholar
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex OA
Cited by 122
Semantic Scholar
Functional relevance of histone demethylase JARID1B (KDM5B) in breast cancer
Cited by 0
Semantic Scholar
JARID1B is a luminal lineage-driving oncogene in breast cancer. OA
Cited by 178
Semantic Scholar
Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. OA
Cited by 300
Semantic Scholar
Research Topics
Gyrotron and Vacuum Electronics Research
(49)
Orbital Angular Momentum in Optics
(47)
Terahertz technology and applications
(44)
Computational Drug Discovery Methods
(39)
RNA modifications and cancer
(39)
Affiliations
BGI Group (China)
Harbin University of Science and Technology
South China Agricultural University
Xihua University
Shenyang Pharmaceutical University